DT&CRO Co

DT&CRO Co CapEx/D&A

The CapEx to Depreciation Ratio of DT&CRO Co (383930.KQ) as of Oct 31, 2026 is 57.71. In the previous year, CapEx to Depreciation Ratio was 43.04 — a change of 34.07% (higher).

CapEx/D&A

57.71

YoY

34.07%

Last updated:

CapEx to Depreciation Ratio of DT&CRO Co is 2024 57.71 . CapEx to Depreciation Ratio of DT&CRO Co was 2023 43.04 . It decreases by 34.07% higher compared to the previous year.

The DT&CRO Co CapEx/D&A history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/D&A
Date
CapEx/D&A
Jan 1, 2019
39.03 KRW
Jan 1, 2020
18.44 KRW
Jan 1, 2022
43.04 KRW
Jan 1, 2024
57.71 KRW
The DT&CRO Co CapEx/D&A history
YEARCapEx/D&AYoY
57.71+34.07%
43.04+133.46%
18.44-52.77%
39.03—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DT&CRO Co Stock analysis

What does DT&CRO Co do? DT&CRO Co Ltd is a South Korean company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Based in Yongin, the company has 277 employees and completed its initial public offering (IPO) on November 11, 2022. DT&CRO Co Ltd provides non-clinical and clinical trial services for pharmaceuticals, medical devices, food, chemicals, and cosmetics. The company also offers analysis, efficacy evaluation, and related services. Its headquarters are located in Yongin, Gyeonggi-Do, South Korea. The company's website is www.dtncro.com. DT&CRO Co Ltd is engaged in research and development activities related to medicine and pharmaceuticals, though specific details about its R&D focus or product offerings are not provided in the available information. The company operates as a service provider in the life sciences sector, supporting various industries through trial services and analytical solutions. As a publicly traded company, it is listed under the ticker symbol 383930.KQ with ISIN KR7383930005. The company's operations are centered on delivering specialized services to clients in the pharmaceutical and related industries, emphasizing both non-clinical and clinical trial support. DT&CRO Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DT&CRO Co stock

CapEx to Depreciation Ratio of DT&CRO Co is 57.71 in 2024.

CapEx to Depreciation Ratio of DT&CRO Co changed from 43.04 to 57.71, representing a 34.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio DT&CRO Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's DT&CRO Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — DT&CRO Co

All Key Metrics — DT&CRO Co